A licence to cure: when there is sufficient evidence of quality, efficacy, and safety, the cheapest product should be prescribable

Jeffrey K Aronson, Robin Ferner

Research output: Contribution to journal › Editorial

1 Citation (Scopus)

Access to Document

@article{1b08134405844635bf31bd7885f92cab,

title = "A licence to cure: when there is sufficient evidence of quality, efficacy, and safety, the cheapest product should be prescribable",

author = "Aronson, {Jeffrey K} and Robin Ferner",

year = "2015",

month = apr,

day = "1",

doi = "10.1136/bmj.h1723",

language = "English",

volume = "350",

journal = "BMJ",

issn = "0959-8138",

publisher = "BMJ Publishing Group",

}